Norethindrone

Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.

Cross Reference

Introduction

To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Norethindrone?

Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Norethindrone

MeSH term MeSH ID Detail
Arteriosclerosis D001161 86 associated lipids
Body Weight D001835 333 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Norethindrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Norethindrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Norethindrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Norethindrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Norethindrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Norethindrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Norethindrone

Download all related citations
Per page 10 20 50 100 | Total 3869
Authors Title Published Journal PubMed Link
Rowan JP "Estrophasic" dosing: A new concept in oral contraceptive therapy. 1999 Am. J. Obstet. Gynecol. pmid:9988834
Mills TM et al. Metabolism of oral contraceptive drugs. The formation and disappearance of metabolites of norethindrone and mestranol after intravenous and oral administration. 1976 Am. J. Obstet. Gynecol. pmid:998688
Al-Azzawi F et al. Continuous combined hormone replacement therapy compared with tibolone. 1999 Obstet Gynecol pmid:9932566
Ohman L et al. Topical administration of progestational steroids in the eye and nose--a rapid absorption to the blood. 1978 Contraception pmid:99284
Weiner E and Johansson ED The influence of norethisterone oenanthate on ovarian function. 1976 Acta Endocrinol. pmid:989667
Rowlands SC and Dakin L Twelve years of injectable contraceptive use in a general practice. 1998 Br J Fam Plann pmid:9882767
Briatico G et al. Effects of contraceptive agents on drug metabolism in various animal species. 1976 Br. J. Pharmacol. pmid:987822
Raudaskoski T et al. Plasma insulin-like growth factor-I and its binding proteins 1 and 3 during continuous nonoral and oral combined hormone replacement therapy. 1998 Menopause pmid:9872487
Trapnell CB et al. Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone. 1998 Clin. Pharmacol. Ther. pmid:9871424
Ladinsky H et al. Lack of influence of the phase of estrus cycle or treatment with steroid contraceptive drugs on cholinergic parameters in mouse and rat brain. 1976 Pharmacology pmid:986656
Darj E et al. Ultrasonographic blood flow measurement in the carotid arteries in postmenopausal women. 1999 Gynecol. Obstet. Invest. pmid:9852387
Hägglund H et al. Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation. 1998 Blood pmid:9845522
Yadava HS et al. Effect of low dose norethindrone acetate released through subdermal silastic implant on lipid metabolism in female rhesus monkeys. 1978 Indian J. Exp. Biol. pmid:98430
Lamble JW and Lamble AP Some effects of progestogens, oestrogens and androgens on the ocular tension of rabbits and owl monkeys. 1978 Exp. Eye Res. pmid:98336
LeBel M et al. Effects of rifabutin and rifampicin on the pharmacokinetics of ethinylestradiol and norethindrone. 1998 J Clin Pharmacol pmid:9824786
Sturdee DW et al. Glucose tolerance and hormone replacement therapy. A preliminary study. 1976 Postgrad Med J pmid:981120
Burnett D et al. Plasma protein changes in post-menopausal women receiving mestranol-norethisterone hormone replacement therapy. 1976 Postgrad Med J pmid:981119
Moore B Sequential mestranol and morethisterone in the treatment of the climacteric syndrome. 1976 Postgrad Med J pmid:981118
Verhoeven CH et al. In vitro and in vivo metabolism of the progestagen Org 30659 in several species. 1998 Drug Metab. Dispos. pmid:9806953
Berg G et al. Effect of oral contraceptive progestins on serum copper concentration. 1998 Eur J Clin Nutr pmid:9805216
Martelli A et al. Induction of micronuclei and of enzyme-altered foci in the liver of female rats exposed to progesterone and three synthetic progestins. 1998 Mutat. Res. pmid:9804880
Lachnit-Fixson U and Aydinlik S [New cycle-stabilizing contraceptive agent (Ediwal)]. 1976 Med Monatsschr pmid:979900
Rogers A and Eastell R Effects of estrogen therapy of postmenopausal women on cytokines measured in peripheral blood. 1998 J. Bone Miner. Res. pmid:9783546
Cacciatore B et al. Randomized comparison of oral and transdermal hormone replacement on carotid and uterine artery resistance to blood flow. 1998 Obstet Gynecol pmid:9764629
Funckes CG et al. Effect of a long-acting contraceptive drug, norethindrone enanthate, on serum zinc and copper in human volunteers. 1976 Contraception pmid:975819
Fotherby K and Warren RJ Bioavailability of contraceptive steroids from capsules. 1976 Contraception pmid:975817
Sturdee DW et al. Pregnancy associated alpha2-glycoprotein in post-menopausal women receiving hormone replacement therapy. 1976 Clin. Chim. Acta pmid:975579
Tant D Megaloblastic anaemia due to pyridoxine deficiency associated with prolonged ingestion of an oestrogen-containing oral contraceptive. 1976 Br Med J pmid:974714
Gal I Hormonal pregnancy tests and congenital malformations. 1976 Br Med J pmid:974708
Hammar M et al. A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms. 1998 Br J Obstet Gynaecol pmid:9746385
Kaba S et al. Endometrial cytology in postmenopausal hormone replacement therapy. 1998 Diagn. Cytopathol. pmid:9740987
Barkin JS and Ross BS Medical therapy for chronic gastrointestinal bleeding of obscure origin. 1998 Am. J. Gastroenterol. pmid:9707046
Moyer DL and Felix JC The effects of progesterone and progestins on endometrial proliferation. 1998 Contraception pmid:9693400
Bech P et al. Combined versus sequential hormonal replacement therapy: a double-blind, placebo-controlled study on quality of life-related outcome measures. 1998 Jul-Oct Psychother Psychosom pmid:9693354
Picazo O et al. A-ring reduced derivatives of two synthetic progestins induce anxiolytic effects in ovariectomized rats. 1998 Brain Res. pmid:9689453
Arteaga E et al. In vitro effect of estradiol, progesterone, testosterone, and of combined estradiol/progestins on low density lipoprotein (LDL) oxidation in postmenopausal women. 1998 Menopause pmid:9689190
Ostad SN et al. In vitro cytotoxicity and teratogenicity of norethisterone and levonorgestrel released from hollow nylon monofilaments. 1998 J Control Release pmid:9685884
Powles TJ et al. The effects of norethisterone on endometrial abnormalities identified by transvaginal ultrasound screening of healthy post-menopausal women on tamoxifen or placebo. 1998 Br. J. Cancer pmid:9683306
Anzaldua SR et al. Differential effects of 5 alpha-norethisterone on the histomorphology of the oviduct and uterus of the pregnant rabbit. 1998 Contraception pmid:9673843
Irvine GA et al. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. 1998 Br J Obstet Gynaecol pmid:9647148
Duckitt K and Shaw RW Is medical management of menorrhagia obsolete? 1998 Br J Obstet Gynaecol pmid:9647144
Stadberg E Research in progress. 1998 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:9643395
Liskowski L et al. The determination of progesterone receptors in breast cancer and their relationship to estrogen receptors. 1976 Clin. Chim. Acta pmid:963895
Alexandersen P et al. Norethindrone acetate enhances the antiatherogenic effect of 17beta-estradiol: a secondary prevention study of aortic atherosclerosis in ovariectomized cholesterol-fed rabbits. 1998 Arterioscler. Thromb. Vasc. Biol. pmid:9633929
Surrey ES Add-back therapy: extending safety and efficacy of GnRH analogues in the gynecologic patient. 1998 Gynecol. Obstet. Invest. pmid:9628522
Lindheimer MD et al. Oral-contraceptive-induced hypertension after adrenalectomy and hypophysectomy. 1976 Arch. Intern. Med. pmid:962446
Lei KY et al. Oral contraceptives, norethindrone and mestranol: effects on tissue levels of minerals. 1976 Am. J. Physiol. pmid:961877
Coutinho EM et al. The response of the human Fallopian tube to ergonovine and methyl-ergonovine in vivo. 1976 Am. J. Obstet. Gynecol. pmid:961746
Zeng X and Yao Z Experimental study on relationship between exogenous estrogen and breast cancer risk. 1997 Chin. Med. J. pmid:9594309
Ylikorkala O et al. The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane. 1998 Fertil. Steril. pmid:9591497
Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on glucose metabolism and liver function. United Nations Development Programme/United Population Fund/World Health Organization/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation. 1998 Contraception pmid:9589832
Marik JJ Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. 1998 Obstet Gynecol pmid:9572232
Eldon MA et al. Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol. 1998 Neurology pmid:9566412
Letterie GS A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation. 1998 Contraception pmid:9554249
Rubens RD et al. Norethisterone acetate in the treatment of advanced breast cancer. 1976 Eur J Cancer pmid:954799
Kohnen G et al. Endothelin receptor expression in human decidua. 1998 Mol. Hum. Reprod. pmid:9542978
Stead DA et al. Capillary electrochromatography of steroids increased sensitivity by on-line concentration and comparison with high-performance liquid chromatography. 1998 J Chromatogr A pmid:9542140
Muneyyirci-Delale O and Karacan M Effect of norethindrone acetate in the treatment of symptomatic endometriosis. 1998 Jan-Feb Int J Fertil Womens Med pmid:9532466
Glusa E et al. Mechanisms of relaxation of rat aorta in response to progesterone and synthetic progestins. 1997 Maturitas pmid:9522326
Lübbert H and Nauert C Continuous versus cyclical transdermal estrogen replacement therapy in postmenopausal women: influence on climacteric symptoms, body weight and bleeding pattern. 1997 Maturitas pmid:9522319
Mulder TP et al. Effects of hormone replacement therapy on plasma glutathione S-transferase A1-1 concentrations in healthy postmenopausal women. 1998 Clin. Chem. pmid:9510879
Leach M et al. Norethisterone therapy for bleeding due to gastrointestinal telangiectases in Glanzmann's thrombasthenia. 1998 Br. J. Haematol. pmid:9504647
Sinofsky FE and Pasquale SA The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives. 1998 Am. J. Obstet. Gynecol. pmid:9500490
el-Heneidy AR et al. The effect of an oral contraceptive on the pulmonary functions. 1976 Contraception pmid:949891
Kuhnz W et al. In vivo conversion of norethisterone and norethisterone acetate to ethinyl etradiol in postmenopausal women. 1997 Contraception pmid:9494772
Luckas MJ et al. The effect of progestagens on the carotid artery pulsatility index in postmenopausal women on oestrogen replacement therapy. 1998 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:9481579
Hornstein MD et al. Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group. 1998 Obstet Gynecol pmid:9464714
Edwards JP et al. 5-Aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines as potent, orally active, nonsteroidal progesterone receptor agonists: the effect of D-ring substituents. 1998 J. Med. Chem. pmid:9464361
Norethin: lower cost can improve OC compliance. 1997 Adv Nurse Pract pmid:9460009
Hyder SM et al. Progestin regulation of vascular endothelial growth factor in human breast cancer cells. 1998 Cancer Res. pmid:9458078
Andersen RN et al. Response of the binding capacity of plasma testosterone-estradiol-binding globulin to norethindrone, 2 mg., and mestranol, 0.1 mg., in polycystic ovarian disease. 1976 Am. J. Obstet. Gynecol. pmid:944533
Dickey RP et al. Estrogen potencies of three new low-dose oral contraceptives. 1976 Am. J. Obstet. Gynecol. pmid:941952
Shetty G et al. Use of norethisterone and estradiol in mini doses as a contraceptive in the male. Efficacy studies in the adult male bonnet monkey (Macaca radiata). 1997 Contraception pmid:9408708
Weisberg E et al. Effect of different insertion regimens on side effects with a combination contraceptive vaginal ring. 1997 Contraception pmid:9408704
Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on lipid and lipoprotein metabolism. United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction. 1997 Contraception pmid:9408700
De Aguilar MA et al. Current status of injectable hormonal contraception, with special reference to the monthly method. 1997 Adv Contracept pmid:9404550
Beier S et al. The progestational activity of different gestagens used for human contraception in the beagle bitch. 1979 Contraception pmid:94000
Mc Manus J et al. The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women. 1997 Atherosclerosis pmid:9395275
Ulrich LG et al. Quality of life and patient preference for sequential versus continuous combined HRT: the UK Kliofem multicenter study experience. UK Continuous Combined HRT Study Investigators. 1997 Int J Gynaecol Obstet pmid:9386211
Marcucci F et al. Effect of estrogen-progestin combinations on the hepatic microsomal metabolism of mestranol. 1976 Biochem. Pharmacol. pmid:938556
Wiese J et al. Long-term contraception with norethindrone subcutaneous capsules. 1976 Ann. Clin. Res. pmid:937998
Herbai G and Werner I Sheehan's syndrome of hypothalamic origin in a woman with juvenile diabetes mellitus. 1976 Acta Med Scand pmid:937082
Kullander S and Källén B A prospective study of drugs and pregnancy. 3. Hormones. 1976 Acta Obstet Gynecol Scand pmid:936986
Haines CJ et al. Sonographic measurement of endometrial thickness as a predictor of vaginal bleeding in women using continuous combined hormone replacement therapy. 1997 Gynecol. Obstet. Invest. pmid:9359646
Jasonni VM et al. Transdermal progestins in hormone replacement therapy. 1997 Ann. N. Y. Acad. Sci. pmid:9329856
Rossmanith WG et al. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity. 1997 Contraception pmid:9306028
Ravinder P et al. Pharmacokinetics of orally administered norethisterone enanthate in rabbit, monkey, and women. 1997 Contraception pmid:9262934
Hess FM et al. Effect of low zinc intake and oral contraceptive agents on nitrogen utilization and clinical findings in young women. 1977 J. Nutr. pmid:925768
Alfie J et al. Hemodynamic effects of transdermal estradiol alone and combined with norethisterone acetate. 1997 Maturitas pmid:9255751
Haapasaari KM et al. Systemic therapy with estrogen or estrogen with progestin has no effect on skin collagen in postmenopausal women. 1997 Maturitas pmid:9255750
Litschgi M and Glatthaar E [A casuistic contribution to therapy with gestagen in metastasizing corpus carcinoma (author's transl)]. 1977 Geburtshilfe Frauenheilkd pmid:924094
Laumas KR Recent progress in the development of long-acting injectables for control of human fertility. 1977 J Obstet Gynaecol India pmid:923990
Saleh FM and Abd-el-Hay MM Liver function tests after the use of long-acting progestational contraceptives. 1977 Contraception pmid:923251
Saleh FM Serium protein-bound carbohydrate and seromucoid levels during long-acting progestational contraceptive therapy. 1977 Contraception pmid:923250
Seth U et al. Effect of a subdermal silastic implant containing norethindrone acetate on human lactation. 1977 Contraception pmid:923249
Diffey B et al. The effect of oral contraceptive agents on the basal metabolic rate of young women. 1997 Br. J. Nutr. pmid:9227183
Benagiano G et al. Comparative clinical evaluation of the effect on carbohydrate and lipid metabolism of two norethisterone-containing hormonal contraceptives: Mesigyna and TriNovum. 1997 Contraception pmid:9220226
Moretti G et al. [Simultaneous determination using gas chromatography of mestranol and norethisterone in estrogen-progestins combination for oral use]. 1977 Boll Chim Farm pmid:921851
Herz JE et al. Preparation of 19-nor-17alpha-ethinyltestosterone pivalate ester. 1977 Steroids pmid:919011
Singh M et al. Contraceptive efficacy of norethindrone encapsulated in injectable biodegradable poly-dl-lactide-co-glycolide microspheres (NET-90): phase III clinical study. 1997 Adv Contracept pmid:9181181